<DOC>
	<DOCNO>NCT01704170</DOCNO>
	<brief_summary>This study prospective , multi-center trial wherein include subject receive experimental externally focus ultrasound renal denervation therapy . It conduct maximum fifty patient meet inclusion exclusion criterion sign informed consent form . Safety primary endpoint study assess incidence evaluation serious adverse effect associate investigational procedure 52-week evaluation . Clinical utility secondary endpoint study evaluate assess pre post therapy systolic diastolic blood pressure .</brief_summary>
	<brief_title>Feasibility Study Evaluate Renal Denervation Using Focused Ultrasound</brief_title>
	<detailed_description />
	<mesh_term>Hypertension</mesh_term>
	<criteria>Subject least 18 year age . Subject systolic blood pressure 160 mmHg average great . Subject refractory , stable hypertension despite treat least three hypertensive drug . Subject two functioning kidney , define eGFR â‰¥ 45 ml/min . Subject least one renal artery side great 4mm . Subject hydronephrosis see MRA ultrasound . Subject renal stenosis great 50 % base baseline MRA . Subject renal stent implant region . Subject kidney stone symptomatic and/or great 1cm discretion investigator may interfere treatment . Subject history abdominal surgery within past six month . Subject heterogeneity kidney large cyst tumor discretion investigator may interfere treatment . Subject active pyelonephritis history pyelonephritis discretion investigator may interfere treatment . Subject history myocardial infarction , unstable angina pectoris , cerebrovascular accident within last six month . Subject hemodynamically significant valvular heart disease . Subject implantable cardioverter defibrillator , pacemaker , neurostimulator device incompatible MRI . Subject body weight &gt; 150 kilogram . Subject target treatment depth &gt; 14 cm . Subject pregnant , nursing intend become pregnant trial period . Subject currently enrol potentially confound research . Subject condition , discretion investigator , would preclude participation trial .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
</DOC>